Evidence map›Paper›PMID 40033995›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2025

CRISPR-Responsive Reprogrammable Label-Free Fluorescent Nanoclusters for ML-Assisted Pathogenic Genome Detection on Solid Substrates.

Emmett Hanson, Nabeel Kalla, Ram Jeevan Tharu, Mikail M Demir, Betul H Tok, M Abdullah Canbaz, Mehmet V Yigit

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Article
  3. Effects of NBioconjugate chemistry · 2025
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emmett HansonDepartment of Chemistry, University at Albany, State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.ORCID 0009-0000-9727-9682
Nabeel KallaDepartment of Chemistry, University at Albany, State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.ORCID 0009-0008-8003-5655
Ram Jeevan TharuDepartment of Chemistry, University at Albany, State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.ORCID 0009-0001-2402-1346
Mikail M DemirDepartment of Information Sciences and Technology, AI in Complex Systems Laboratory, University at Albany, State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.
Betul H TokDepartment of Information Sciences and Technology, AI in Complex Systems Laboratory, University at Albany, State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.
M Abdullah CanbazDepartment of Information Sciences and Technology, AI in Complex Systems Laboratory, University at Albany, State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.ORCID 0000-0001-5407-6789
Mehmet V YigitDepartment of Chemistry, University at Albany, State University of New York, 1400 Washington Avenue, Albany, NY, 12222, USA.ORCID 0000-0002-4349-3701

Funding

DNA nanotechnology and synthetic biology for AI-supported detection and precision therapeuticsR35GM156250 · NIGMS · STATE UNIVERSITY OF NEW YORK AT ALBANY · PI Mehmet Veysel Yigit · 2025 to 2026
$779k
National Institute of Food and Agriculture 2022-08596National Institute of General Medical Sciences of the National Institutes of Health 1R35GM156250-01NIGMS NIH HHS 1R35GM156250-01NIGMS NIH HHS R35 GM156250USDA National Institute of Food and Agriculture (NIFA) 2022-08596
6 · The paper itself

Abstract

The development of a paper-based genome detection assay using target-responsive DNA-templated silver nanoclusters (DFN-1) is presented. The reported nanoclusters exhibit intrinsic fluorescence, which is regulated by the cleavage of the DNA template surrounding the silver core. To enable the nanoclusters to respond to a specific genome, CRISPR-Cas12a is employed for highly specific and programmable digestion of the nanoclusters. Upon detection of the target, the DNA template is cleaved by the CRISPR-Cas12a complex, leading to a reduction in fluorescence. This assay successfully demonstrates for the detection of the Salmonella genome in the liquid phase and on 2 mm solid filter paper discs. By altering only the crRNA in the CRISPR complex, the assay is programmed to detect two different Salmonella serotypes. The selectivity of the assay is evaluated in DNA mixtures with and without the target genomic fragments. The assay also demonstrates the detection of as little as 33 copies of the full Salmonella genome by incorporating an isothermal amplification step. Furthermore, 60 unknown samples with different target content in standard 344 well plates are evaluated. The results are analyzed using custom-developed machine-learning algorithms, successfully detecting the presence of the target with 100% prediction accuracy.

Indexed as

CRISPR-Cas SystemsGenome, BacterialMetal NanoparticlesSalmonellaFluorescenceSilverSilverCRISPRfluorescencegenomessensorssilver nanoclusters

Identifiers

PMID40033995
PMCPMC12060729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.